Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases.
Leticia Kawano-DouradoTejaswini KulkarniChristopher J RyersonPilar Rivera-OrtegaAndré Luis Pereira de AlbuquerqueNazia ChaudhuriManuela Funke-ChambourAnna-Maria Hoffmann-VoldKerri A JohannsonYet Hong KhorSydney B MontesiLucilla PiccariHelmut ProschMaría Molina-MolinaJacobo SellarésIazsmin Bauer-VenturaSujeet RajanJoseph JacobDuncan B RichardsLisa G SpencerBarbara WendelbergerTom JensenMelanie QuintanaMichael KreuterAnthony C GordonFernando J MartinezNaftali KaminskiVictoria CorneliusRoger LewisWendy AdamsR Gisli Jenkinsnull nullPublished in: Thorax (2024)
By using an innovative and efficient adaptive multi-interventional trial platform design, we aim to accelerate and improve care for patients with fILD. Through worldwide collaboration, novel analytical methodology and pragmatic trial delivery, REMAP-ILD aims to overcome major limitations associated with conventional randomised controlled trial approaches to rapidly improve the care of people living with fILD.